0000000000928250

AUTHOR

A Augello

showing 5 related works from this author

Bendamustin in association with Rituximab (BR) in the treatment of patients with relapsed/refractory lymphoid neoplasm. A GISL retrospective study

2009

Lymphoid neoplasms bendamustinSettore MED/15 - Malattie Del Sangue
researchProduct

BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA

2010

At present, a prospectively validated treatment for SMZL is lacking. Despite this fact, splenectomy is still deemed to be the best choice for patients requiring treatment. Nevertheless, the high fraction of patients achieving a clinical response following splenectomy eventually relapses or progresses

splenic marginal zone lymphomabendamustineSettore MED/15 - Malattie Del Sangue
researchProduct

Lymphonodal amyloidosis: case report

2009

Amyloidosis lymphomaSettore MED/15 - Malattie Del Sangue
researchProduct

ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA

2011

multiple myelomaSettore MED/15 - Malattie Del Sangue
researchProduct

PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS: A SINGLE INSTITUTION EXPERIENCE

2012

PJP infection Haematological neoplasmsSettore MED/15 - Malattie Del Sangue
researchProduct